A detailed history of Clear Harbor Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 32,558 shares of ABBV stock, worth $5.58 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
32,558
Previous 33,191 1.91%
Holding current value
$5.58 Million
Previous $5.14 Million 15.26%
% of portfolio
0.53%
Previous 0.48%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $101,166 - $115,269
-633 Reduced 1.91%
32,558 $5.93 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $119,574 - $134,668
-869 Reduced 2.55%
33,191 $5.14 Million
Q3 2023

Oct 26, 2023

SELL
$133.59 - $154.65 $13,359 - $15,465
-100 Reduced 0.29%
34,060 $5.08 Million
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $684,546 - $851,873
5,166 Added 17.82%
34,160 $4.6 Million
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $2.12 Million - $2.44 Million
14,648 Added 102.11%
28,994 $4.62 Million
Q3 2022

Oct 24, 2022

SELL
$134.21 - $153.93 $6,710 - $7,696
-50 Reduced 0.35%
14,346 $1.93 Million
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $5,504 - $6,998
-40 Reduced 0.28%
14,396 $2.21 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $178,832 - $221,881
-1,355 Reduced 8.58%
14,436 $2.34 Million
Q4 2021

Jan 21, 2022

SELL
$107.43 - $135.93 $8,379 - $10,602
-78 Reduced 0.49%
15,791 $2.14 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $27,983 - $31,765
263 Added 1.69%
15,869 $1.71 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $3,156 - $3,516
30 Added 0.19%
15,606 $1.76 Million
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $33,042 - $36,376
323 Added 2.12%
15,576 $1.69 Million
Q4 2020

Feb 04, 2021

SELL
$80.49 - $108.67 $14,246 - $19,234
-177 Reduced 1.15%
15,253 $1.63 Million
Q2 2020

Aug 05, 2020

BUY
$73.37 - $98.18 $246,376 - $329,688
3,358 Added 27.82%
15,430 $1.52 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $32,250 - $48,895
500 Added 4.32%
12,072 $920,000
Q4 2019

Jan 29, 2020

BUY
$72.13 - $90.25 $108,195 - $135,375
1,500 Added 14.89%
11,572 $1.02 Million
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $2,880 - $3,552
37 Added 0.37%
10,072 $929,000
Q1 2018

May 01, 2018

BUY
$92.01 - $123.21 $17,941 - $24,025
195 Added 1.98%
10,035 $950,000
Q4 2017

Jan 23, 2018

BUY
$89.56 - $98.21 $35,824 - $39,284
400 Added 4.24%
9,840 $952,000
Q3 2017

Oct 25, 2017

BUY
$69.85 - $89.22 $659,384 - $842,236
9,440
9,440 $839,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clear Harbor Asset Management, LLC Portfolio

Follow Clear Harbor Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.